MyETF.app
HomeUS Marketequity › BBH

BBH — VanEck Biotech ETF

VanEck Biotech ETF (ticker: BBH) is a equity ETF issued by VanEck tracking MVIS US Listed Biotech 25. It was launched on 2011-12-20.

Live Price$185.3
Change2.34%
AUM$353.69M
Expense Ratio0.00%
Avg Volume4,926.1

Returns (Total Return)

PeriodReturn
1 Day2.22%
1 Week0.59%
1 Month1.43%
3 Months-3.41%
6 Months-5.79%
YTD-1.84%
1 Year23.31%
3 Years18.97%
5 Years2.81%
10 Years
Since Inception

Top Holdings

#SecuritySymbolWeight
1 Amgen Inc AMGN 17.85%
2 Amgen Inc AMGN 17.85%
3 Amgen Inc AMGN 17.85%
4 Amgen Inc AMGN 17.85%
5 Amgen Inc AMGN 17.85%
6 Amgen Inc AMGN 17.16%
7 Amgen Inc AMGN 17.16%
8 Amgen Inc AMGN 17.16%
9 Amgen Inc AMGN 17.16%
10 Amgen Inc AMGN 17.10%

Fund Profile

IssuerVanEck
BrandVanEck
Asset Classequity
StrategyVanilla
StructureETF
CategoryHealth & Biotech Equities
SegmentEquity: Global Biotechnology
SectorBiotechnology
RegionNorth America
Index TrackedMVIS US Listed Biotech 25
Inception Date2011-12-20
Tax on DistributionsQualified dividends

Quick Facts

TickerBBH
Full NameVanEck Biotech ETF
IssuerVanEck
Asset Classequity
Expense Ratio0.00%
AUM$353.69M
Inception2011-12-20
Index TrackedMVIS US Listed Biotech 25

Frequently Asked Questions

What does BBH track?

BBH (VanEck Biotech ETF) tracks MVIS US Listed Biotech 25, a equity benchmark.

What is the expense ratio of BBH?

BBH has an expense ratio of 0.00% per year.

What is the AUM of BBH?

BBH has approximately $353.69M in assets under management.

Does BBH pay a dividend?

BBH distributes income according to its prospectus (Qualified dividends tax treatment). Check the dividend history tab for ex-dividend dates and yield.

Who issues BBH?

BBH is issued by VanEck, launched on 2011-12-20.

Open the interactive BBH dashboard for charts, historical fund flows, holdings breakdown and seasonality patterns.